21096 ⎘
Medicinal preparations containing antigens or antibodies; Bacterial antigens streptococcus Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus Streptococcus
Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#302Immunogenic composition
#303Process for preparing pneumococcal polysaccharide-protein conjugates
#304Immunogenic composition
#305Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#306Saccharide-polypeptide conjugate compositions and methods of use thereof
#307Personalized Site-Specific Immunomodulation
#308Methods and compositions relating to adjuvants
#309Method of identifying a biologically-active composition from a biofilm
#310Image processing of streptococcal infection in pharyngitis subjects
#311Methods and compositions using highly conserved pneumococcal surface proteins
#312METHODS FOR IMPROVING FILTERABILITY OF POLYSACCHARIDE-PROTEIN CONJUGATE REACTIONS
#313Diagnosis and treatment of infection involving killer t follicular helper cells, methods of preparation, and uses thereof
#314Polysaccharide-protein conjugates utilizing diphtheria toxin fragment B as a carrier
#315LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
#316Conjugated vaccine carrier proteins
#317Enhancing immunogenicity of polysaccharide-protein conjugates
#318Methods for making polysaccharide-protein conjugates
#319RNA BACTERIAL VACCINES
#320COMPOSITION COMPRISING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS FOR PREVENTING, ALLEVIATING, OR TREATING AGING
#321Mixtures of polysaccharide-protein pegylated compounds
#322Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
#323Synthetic vaccines against serotype 2
#324IMMUNOGENIC COMPOSITION
#325DNA vector and transformed tumor cell vaccines
#326Process for preparing pneumococcal polysaccharide-protein conjugates
#327Ex vivo antigen and adjuvant pulsed peripheral blood mononuclear cells as a screening platform for candidate novel vaccines and candidate antigens
#328vaccine
#329Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#330Pneumococcal vaccine combining selected alpha helical domains and proline rich domains of pneumococcal surface protein A
#331Pneumococcal dosing regimen
#332Immunogenic compositions for use in pneumococcal vaccines
#333Vaccine for protection against
#334Glycoconjugation process
#335Microparticles from as vaccine antigens
#336Pneumococcal vaccine formulations
#337Immunogenic composition
#338Antimicrobial extracts of Boswellia and thyme
#339IMMUNOGENIC COMPOSITIONS COMPRISING SBI PROTEIN AND USES THEREOF
#340Modified host cells and hybrid oligosaccharides for use in bioconjugate production
#341Immunogenic complex for eliciting protective immunity against group b streptococcus
#342Vaccine
#343Group A streptococcus vaccine
#344Immunogenic Composition
#345Dimethyl fumarate and vaccination regimens
#346Method for the production of protein complexes and vaccine compositions comprising the same
#347vaccines to protect against reproductive, nursery-age, and growing pig diseases and methods of making and use thereof
#348Pneumococcal polysaccharide-protein conjugate composition
#349Multivalent pneumococcal conjugate vaccine
#350Adjuvant System for Vaccine Administration
#351Multivalent glycoconjugate vaccines
#352Multivalent glycoconjugate vaccines
#353Multivalent pneumococcal vaccine compositions comprising polysaccharide-protein conjugates
#354Compositions comprising polysaccharide-protein conjugates and methods of use thereof
#355Compounds and methods for affecting cytokines
#356Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#357Therapeutically triggering an innate immune response in a target tissue
#358Modified biotin-binding protein, fusion proteins thereof and applications
#359ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#360Multivalent VLP conjugates
#361Method for inhibiting, improving, or preventing aging using recombinant fusion protein of pathogenic antigen protein and flagellin of
#362Production of recombinant vaccine in by enzymatic conjugation
#363Composition for Immunization Against Streptococcus Pneumoniae
#364STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDES AND CONJUGATES THEREOF
#365Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
#366Oil-based adjuvants
#367extract as an immunogenic agent
#368Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#369Polysaccharide purification for vaccine production using lytic enzymes, tangential flow filtration, and multimode chromatography
#370capsular polysaccharides and conjugates thereof
#371Immunogenic compositions for use in pneumococcal vaccines
#372Low, immune enhancing, dose MTOR inhibitors and uses thereof
#373Compositions and methods for stabilization of active agents
#374LIPIDATED STREPTOCOCCUS PNEUMONIAE ANTIGEN COMPOSITIONS, METHODS OF PREPARATION AND USE
#375Multivalent conjugate vaccines with bivalent or multivalent conjugate polysaccharides that provide improved immunogenicity and avidity
#376Method of identifying a biologically-active composition from a biofilm
#377Polypeptide-antigen conjugates with non-natural amino acids
#378Pneumolysin mutants and methods of use thereof
#379Immunogenic fusion protein
#380Vaccine
#381Use of immunomodulatory kits for immunotherapeutic treatment of patients with myeloid leukemias
#382HU specific interfering agents
#383Vaccines against serotype 5
#384Immunogenic composition for preventing pneumococcal diseases and preparation method thereof
#385Methods and compositions using highly conserved pneumococcal surface proteins
#386STREPTOCOCCUS SUIS POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#387Conjunctivitis vaccines
#388Multivalent pneumococcal polysaccharide-protein conjugate composition
#389PROLINE-RICH PEPTIDES PROTECTIVE AGAINST S. PNEUMONIAE
#390Process for preparing pneumococcal polysaccharide-protein conjugates
#391VACCINE COMPRISING STREPTOCOCCUS PNEUMONIAE CAPSULAR POLYSACCHARIDE CONJUGATES
#392Injectable vaccines against multiple meningococcal serogroups
#393Tetanus toxoid and CCL3 improve DC vaccines
#394Glycoconjugation processes and compositions
#395protein antigen, and preparation method and use thereof
#396Pneumococcal capsular saccharide conjugate vaccine
#397Immunogenic compositions containing bacterial outer membrane vesicles
#398Vaccine against infection
#399Glycosylation method
#400FSBM recombinant protein
#401Methods for improving the adsorption of polysaccharide-protein conjugates and multivalent vaccine formulation obtained thereof
#402Method for separation of protein and other impurities from microbial capsular polysaccharides
#403Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
#404FLAGELLIN FUSION PROTEINS AND CONJUGATES COMPRISING PNEUMOCOCCUS ANTIGENS AND METHODS OF USING THE SAME
#405Pneumococcal serotypes
#406Immunogenic compositions and uses thereof
#407Composition comprising recombinant fusion protein of pathogenic antigen protein and flagellin of vibrio vulnificus for preventing, alleviating, or treating aging
#408Streptococcal vaccine
#409Immunogenic composition
#410Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#411Nucleic acids and proteins from streptococcus groups A and B
#412DNA vector and transformed tumor cell vaccines
#413Methods and compositions employing immunogenic fusion proteins
#414Method of preparing bacterial ghosts from gram-positive bacteria by hydrochloric acid treatment
#415Immunogenic composition
#416IMMUNOGENIC COMPOSITIONS
#417Immunogenic compositions for use in pneumococcal vaccines
#418Tissue Targeted Antigenic Activation of the Immune Response to Treat Cancers
#419Lipidated antigen compositions, methods of preparation and use
#420Purification of streptococcal capsular polysaccharide
#421Vaccines against serotype 4
#422Immunogenic proteins and compositions
#423Low, immune enhancing, dose mtor inhibitors and uses thereof
#424Method of identifying a biologically-active composition from a biofilm
#425COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#426FUSION PROTEIN COMPRISING STREPTOCOCCAL ANTIGEN
#427Pneumococcal dosing regimen
#428Conjugation of capsular saccharides
#429Vaccines against serotype 8
#430Polyvalent pneumococcal polysaccharide-protein conjugate composition
#431Modified host cells and hybrid oligosaccharides for use in bioconjugate production
#432Multi-indication mRNA cancer immunotherapy
#433Glycoconjugation processes and compositions
#434Carrier molecule for antigens
#435METHOD FOR CONTROLLING STREPTOCOCCUS PNEUMONIAE POLYSACCHARIDE MOLECULAR WEIGHT USING CARBON DIOXIDE
#436VACCINE COMPOSITION AGAINST STREPTOCOCCUS SUIS INFECTION
#437VACCINE DELIVERY METHOD
#438Streptococcal GlcNac-lacking gylcopolypeptides, cell wall carbohydrates, vaccines, and methods for making and using them
#439Vaccine for immunocompromised hosts
#440METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#441VACCINE
#442Nanoparticles for immune stimulation
#443USES AND COMPOSITIONS FOR TREATMENT OF RHEUMATOID ARTHRITIS
#444Compositions and methods of enhancing immunogenicity of polysaccharide protein conjugates
#445Vaccines and compositions against
#446Immunogenic Compositions
#447Immunogenic composition for modulating the immune system and methods to treat bacterial infections in a subject
#448Multivalent glycoconjugate vaccines
#449AGONISTS AND ANTAGONISTS OF TOLL-LIKE RECEPTOR (TLR) 13
#450Exotoxin/thermolysin compositions and methods and uses for treating or preventing laminitis
#451DNA vector and transformed tumor cell vaccines
#452Purification of secreted polysaccharides from S. agalactiae
#453Multivalent VLP conjugates
#454Vaccine compositions comprising a saponin adjuvant
#455Immunogenic composition
#456Virulence factors of
#457Method of treating protozoal gastrointestinal disorders in immunocompromised patients
#458Method of identifying a biologically-active composition from a biofilm
#459Method of identifying a biologically-active composition from a biofilm
#460Capsular polysaccharide solubilisation and combination vaccines
#461BIOINFORMATIC PROCESSES FOR DETERMINATION OF PEPTIDE BINDING
#462Group A vaccine
#463Multi-functional mucosal vaccine platform
#464Immunogens and methods for discovery and screening thereof
#465Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
#466METHODS FOR PREVENTING AND TREATING STAPHYLOCOCCUS AUREUS COLONIZATION, INFECTION, AND DISEASE
#467Nasal vaccine for
#468Immunogenic glycoprotein conjugates
#469POTENTIATING IMMUNE RESPONSE AGAINST CANCER
#470Immunomodulatory compounds
#471Dimethyl fumarate and vaccination regimens
#472Multivalent pneumococcal polysaccharide-protein conjugate composition
#473Immunogenic compositions and methods
#474Immunogenic proteins and compositions
#475DNA vector and transformed tumor cell vaccines
#476Injectable vaccines against multiple meningococcal serogroups
#477Synthetic vaccines against type 1
#478STREPTOCOCCUS PYOGENES ANTIGENS AND CORRESPONDING DNA FRAGMENTS
#479Group B polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof
#480Streptococcus pneumoniae capsular polysaccharides and conjugates thereof
#481capsular polysaccharides and conjugates thereof
#482Proline-rich peptides protective against
#483Methods and compositions for increasing protective antibody levels induced by pneumococcal polysaccharide vaccines
#484Methods and compositions for the display of polypeptides on the pili of Gram-positive bacteria
#485Integration of meningococcal conjugate vaccination
#486Use of fluorinated cyclic dinucleotides as oral vaccine adjuvants
#487Protein and peptide-free synthetic vaccines against type 3
#488Tetanus toxoid and CCL3 improve DC vaccines
#489Nucleic acids and proteins from streptococcus groups A and B
#490Tissue targeted antigenic activation of the immune response to treat cancers
#491Vaccine comprising capsular polysaccharide conjugates
#492Nasal mucosal vaccine composition
#493Adsorption of immunopotentiators to insoluble metal salts
#494Arabinogalactan for enhancing the adaptive immune response
#495Mucosal vaccine composition
#496Vaccine formulation
#497Mucosal vaccine composition
#498Vaccine
#499MODIFIED POLYSACCHARIDES FOR CONJUGATE VACCINES
#500Cycloalkyne derivatized saccharides
#501METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE
#502Process for preparing pneumococcal polysaccharide-protein conjugates
#503GAS57 MUTANT ANTIGENS AND GAS57 ANTIBODIES
#504Vaccine system for vaccine adjuvant
#505Protein matrix vaccines and related methods of making and administering such vaccines
#506Polysaccharide-protein conjugate vaccines
#507Compounds and methods for affecting cytokines
#508Compositions and methods for treatment of microbial infections
#509Immunization to protect against adverse cardiac events relating to pneumococcal infection
#510Modified biotin-binding protein, fusion proteins thereof and applications
#511COMPOSITION COMPRISING RECOMBINANT FUSION PROTEIN OF PATHOGENIC ANTIGEN PROTEIN AND FLAGELLIN OF VIBRIO VULNIFICUS FOR PREVENTING, ALLEVIATING, OR TREATING AGING
#512Vaccine against streptococcal infections based on recombinant proteins
#513System and Process for Producing Mulit-Component Biopharmaceuticals
#514Methods and compositions employing immunogenic fusion proteins
#515Immunogenic fusion polypeptides
#516Compositions and methods for treatment of microbial infections
#517Nanoparticle-based compositions
#518Modified pneumolysin (PLY) polypeptides
#519Protein antigens that provide protection against pneumococcal colonization and/or disease
#520Nucleic acids and proteins from groups A and B
#521Glycosylation method
#522Synthetic Peptides as Carriers for Conjugation with Polysaccharides
#523MULTIVALENT PNEUMOCOCCAL POLYSACCHARIDE-PROTEIN CONJUGATE COMPOSITION
#524Immunogenic proteins and compositions
#525Tissue targeted antigenic activation of the immune response to treat cancers
#526Vaccines for the treatment of cancer and compositions for enhancing vaccine efficacy
#527Group A Streptococcus Pharmaceutical Compositions and Methods Thereof
#528Glycoconjugation process
#529CONJUGATES FOR PROTECTING AGAINST DIPHTHERIA AND/OR TETANUS
#530Pneumococcal vaccine containing pneumococcal surface protein A
#531VACCINATION ADJUVANT, PREPARATION AND VACCINES CONTAINING THE SAME
#532PRODUCTION OF HETEROLOGOUS POLYSACCHARIDES IN PLANTS
#533Influenza viruses with mutant PB2 segment as live attenuated vaccines
#534PRODUCTION OF RECOMBINANT VACCINE IN E.COLI BY ENZYMATIC CONJUGATION
#535PILUS PROTEINS AND COMPOSITIONS
#536Pneumoccal polysacchride conjugate vaccine
#537Immunomodulating compositions and uses therefor
#538Carbohydrate-glycolipid conjugate vaccines
#539Multivalent pneumococcal polysaccharide-protein conjugate composition
#540Conjugation of streptococcal capsular saccharides
#541Production method for capsular polysaccharide having pneumococcal serotype
#542Immunogenic composition
#543Immunogenic compositions
#544Glycoconjugation processes and compositions
#545IC31 nanoparticles
#546Recombinant strains
#547Adjuvanted combinations of meningococcal factor H binding proteins
#548Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
#549Pneumococcal capsular saccharide conjugate vaccine
#550Polyvalent pneumococcal polysaccharide-protein conjugate composition
#551Meningococcal And Pneumococcal Conjugate Vaccine And Method Of Using Same
#552Chimeric protein vaccine against pneumonia caused by
#553Fermentation of fastidious bacterial strain in perfusion suspension culture
#554Saccharide Conjugate Vaccines
#555Shortened purification process for the production of capsular polysaccharides
#556POLYSACCHARIDE COMPOSITIONS AND METHODS OF USE
#557PNEUMOCOCCAL SEROTYPE 6D
#558Compositions and methods for treatment of microbial infections
#559Method of producing a designer blood product, method of using a designer blood product, and diet for selectively enhancing blood profile
#560LOW, IMMUNE ENHANCING, DOSE MTOR INHIBITORS AND USES THEREOF
#561Oil-based adjuvants
#562VACCINE
#563ADJUVANTED FORMULATIONS OF STREPTOCOCCUS PNEUMONIAE ANTIGENS
#564ADJUVANTED FORMULATIONS OF PEDIATRIC ANTIGENS
#565Glycoengineered outer membrane vesicles and use thereof as vaccines
#566Chimeric Multivalent Polysaccharide Conjugate Vaccines
#567EVOKING PROTECTION AGAINST STREPTOTOCCUS PNEUMONIAE INCORPORATING B-CELL AND T-CELL PNEUMOCOCCAL PROTEIN ANTIGENS AND PNEUMOCOCCAL POLYSACCHARIDES DELIVERED CONCOMITANTLY
#568Prevention of inflammatory disorders in domestic non-human mammals
#569ADJUVANT SYSTEM FOR ORAL VACCINE ADMINISTRATION
#570VACCINE
#571Vaccine
#572Uses and Compositions for Treatment of Rheumatoid Arthritis
#573Fused antigen vaccines and compositions against
#574Bacterial vaccine
#575Immunogenic composition
#576Multivalent pneumococcal polysaccharide-protein conjugate composition
#577GAS57 mutant antigens and GAS57 antibodies
#578Immunogenic compositions and methods
#579Multivalent vaccine protection from infection
#580Composition for immunization against
#581Agonists and antagonists of toll-like receptor (TLR) 13
#582Shortened purification process for the production of capsular polysaccharides
#583MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
#584COMPOSITIONS COMPRISING PNEUMOCOCCAL ANTIGENS
#585Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
#586Modified pneumonia pneumolysin (PLY) polypeptides
#587ORF2 PROTEIN OF PCV2 SUBTYPE A (PCV2A) FOR USE IN CROSS-PROTECTION
#588Pneumococcal dosing regimen
#589Polysaccharide-protein conjugate vaccines
#590Live, attenuated strain and vaccine for protection against pneumococcal disease
#591Multivalent pneumococcal polysaccharide-protein conjugate composition
#592Immunogenic compositions and methods therefor
#593COMPOSITIONS AND METHODS FOR STABILIZATION OF ACTIVE AGENTS
#594Arabinogalactan for enhancing the adaptive immune response
#595Protein F - A Novel Haemophilus Influenzae Adhesin with Laminin and Vitronectin binding Properties
#596Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant
#597Method of detecting the presence of pneumococcal neuraminidases in -infected samples
#598Hypo- and hyper-acetylated meningococcal capsular saccharides
#599Group A streptococcal M-related proteins and methods of use
#600Group A multivalent vaccine